Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand (Q73597514)
Jump to navigation
Jump to search
scientific article published on 01 June 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand |
scientific article published on 01 June 1997 |
Statements
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells (English)
A Falcone
M Lencioni
I Brunetti
E Pfanner
G Allegrini
A Antonuzzo
M Andreuccetti
G Malvaldi